Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE)
Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE)
复制标题
DOI:
10.1007/s40618-015-0349-9
复制
发表时间:
2016-01-01
影响因子:
5.4
通讯作者:
Terzolo, M.
中科院分区:
文献类型:
--
作者:
Stigliano, A.;Chiodini, I.;Terzolo, M.
Accepted: 23 June 2015/Published online: 14 July 2015© Italian Society of Endocrinology (SIE) 2015 advanced ACC remains disappointing for limited efficacy and significant toxicity [1–3]. Management of ACC is challenging for both physicians and their patients and represents one of the most demanding tasks for clinical endocrinologists. However, endocrinologists should be involved in the management of patients with ACC because the disease and its treatment cause a profound derangement of the endocrine system that is harmful for patients and has a negative impact on prognosis. Moreover, endocrinologists play a unique role in the diagnostic process that is too often delayed because patients are not referred to physicians with specific expertise. Thus, presenting symptoms, that are often hormone-related, remain overlooked. On the basis of these considerations, the Italian Society of Endocrinology (SIE) appointed a panel of Italian experts in the field of adrenal diseases with the task to write a Position Statement whose intent was to review and synthesize currently available evidence regarding ACC and provide